Open AccessReview of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder
Author(s) -
Jodi M. Gonzalez,
Paul M. Thompson,
Troy Moore
Publication year - 2011
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s10968
Subject(s) - asenapine , medicine , olanzapine , bipolar i disorder , bipolar disorder , clinical trial , placebo , lithium (medication) , psychiatry , treatment of bipolar disorder , pediatrics , schizophrenia (object oriented programming) , mania , alternative medicine , pathology
Asenapine is approved for acute manic and mixed states in bipolar disorder. The objective is to review the efficacy of asenapine in bipolar disorder, with a particular focus on acceptability and adherence to treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom